Stephanie Harlfinger
Head of Global New Chemical Entities & Drug Metabolism, Pharmacokinetics Merck KGaA
Seminars
Wednesday 17th March 2027
Speaking at the 7th TPD & Induced Proximity Summit Europe
Head of Global New Chemical Entities & Drug Metabolism, Pharmacokinetics Merck KGaA